Transforming STEMI Care: Bridging Interventional and Heart Failure Cardiology to Improve Patient Outcomes
This engaging session features the collaborative efforts of interventional and heart failure cardiologists in revolutionizing the management of ST-Elevation Myocardial Infarction (STEMI) and its impact on heart failure.
Through a dynamic fireside chat format, our esteemed panelists will explore groundbreaking approaches and advancements that are reshaping STEMI care. They will delve into SuperSaturated Oxygen (SSO2) Therapy as a breakthrough treatment post-PCI that extends beyond the focus of only treating the epicardial vessel and into the microvasculature. Discussions will be centered around SSO2 Therapy’s ability to directly address key predictors of heart failure, including microvascular obstruction/dysfunction, infarct size, adverse left ventricular (LV) remodeling, and LV function.
This broadcast is an essential event for cardiologists seeking to optimize STEMI care and elevate patient outcomes, management strategies, and overall quality of life for STEMI patients. Don't miss this opportunity to gain valuable insights from our esteemed panel and stay at the forefront of advancements in STEMI management.
Jerry D Estep
Suzanne J Baron
This broadcast is supported by
- Gain insights into advancements that are reshaping STEMI care and their implications for optimizing patient outcomes
- Understand the importance of treating beyond the epicardial vessel post-PCI and into the microvasculature
- Learn about the role of SuperSaturated Oxygen Therapy as a breakthrough STEMI treatment post-PCI that addresses key predictors of heart failure, including microvascular obstruction/dysfunction, infarct size, adverse LV remodeling, and LV function
- Interventional Cardiologists
- Heart Failure Cardiologists
- Cath Lab Staff
Dr Sandeep Nathan is currently the director of the coronary care unit at the University of Chicago Medicine in Illinois. He specializes in interventional cardiology, regularly performing coronary and peripheral vascular procedures, including transradial angiography. His research interests include balloon angioplasty, stenting, atherectomy, thrombectomy, cryoplasty and IVUS imaging.
Dr Nathan is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
Dr Dan Burkhoff is currently the Director of Heart Failure, Hemodynamics and MCS Research at Cardiovascular Research Foundation, New York, US. Dr Burkhoff's interest include cardiovascular modeling and ventricular mechanics, cardiovascular monitoring, heart failure, device and pharmacologic treatments for heart failure, including left ventricular assist devices. He is also author of Harvi, an interactive simulation-based application for teaching and researching on ventricular mechanics and hemodynamics.
Jerry D Estep
Dr Jerry Estep is a Cardiologist at Cleveland Clinic Florida, Weston, US. He is also the Head of the Section of Heart Failure and Transplantation in the Tomsich Family Department of Cardiovascular Medicine in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute.
Dr Estep's special interests include advanced heart failure, left ventricular assist devices, heart transplantation, echocardiography, cardiac amyloidosis, and coronary angiography.
He earned his medical degree from Baylor College of Medicine, Houston, Texas.
Dr Marat Fudim is a cardiologist, advanced heart failure specialist and assistant professor at Duke University, Durham, US. He has a clinical and research interest in heart failure, including advanced therapies such as mechanical assist devices or "heart pumps" and heart transplantation.
As part of his work, Dr Fudim also performs cardiac catheterizations to understand a patient’s disease.
Dr Michael Lim is a Cardiologist in Saint Louis, Missouri, US. Dr Lim received his medical degree from Wayne State University School of Medicine and has been in practice for over 20 years.
He specializes in cardiovascular disease and interventional cardiology.
Suzanne J Baron
Dr Suzanne Baron is an Interventional Cardiologist at Massachusetts General Hospital, Boston, US. She received her BA from Harvard University, her MD from Yale School of Medicine and her MSc from Harvard School of Public Health.
Dr Baron is involved in research involving the effects of cardiovascular devices on healthcare costs and patient-reported outcomes and she has published on these topics in the Journal of the American College of Cardiology, JAMA Cardiology and Circulation.
She is active within the Society for Cardiovascular Angiography and Interventions and has served as the chair for the Women in Innovations committee as well as the deputy editor for the Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI).